In this episode of the SMA News Today Podcast, I talk with Forums Director Michael Morale about the pharmaceutical company AveXis, and its recent filing for FDA approval of the therapy AVXS-101. This treatment is designed for infants with SMA Type I.
During this discussion, Michael and I talk about when this treatment could be made available, if it will eventually be available for adults with SMA, what it means for SMA patients who are already on Spinraza (nusinersen), and what other treatments for SMA are in development.
Michael and I will be doing these roundtable discussions monthly, and we will tackle a wide range of subjects pertaining to the SMA community. Be sure to subscribe to the SMA News Today Podcast, and share your thoughts in the comments.
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.